Jump to content

Template:Further points for assessing the study: Difference between revisions

From CAMIH
No edit summary
 
No edit summary
 
(4 intermediate revisions by 2 users not shown)
Line 1: Line 1:
<noinclude>
<noinclude>
{{#template_params:Samples sufficiently large (property=Samples sufficiently large)| power analysis performed (property=power analysis performed)| reasons given for samples (property=reasons given for samples)| Ethnicity mentioned (property=Ethnicity mentioned)| Possibility of attention effects (property=Possibility of attention effects)| Possibility of placebo effects (property=Possibility of placebo effects)| Other reasons (property=Other reasons)| Testing for normal distribution (property=Testing for normal distribution)| Correct application of statistical (property=Correct application of statistical)| Correction for multiple testing (property=Correction for multiple testing)| Measurement of compliance (property=Measurement of compliance)| Blinding reliable (property=Blinding reliable)| Check whether blinding was successful (property=Check whether blinding was successful)| Consistent reporting in numbers (property=Consistent reporting in numbers)| Sufficient washout period (property=Sufficient washout period)| Tested for carry-over (property=Tested for carry-over)| Were sequence effects tested (property=Were sequence effects tested)| Comprehensive and coherent reporting (property=Comprehensive and coherent reporting)| Were side effects systematically recorded (property=Were side effects systematically recorded)| Effect sizes reported (property=Effect sizes reported)| Side effects taken into account in the interpretation of the results (property=Side effects taken into account in the interpretation of the results)| mono- or multicentric (property=mono- or multicentric)| Ethics / CoI / Funding (property=Ethics / CoI / Funding)}}
{{#template_params:Samples sufficiently large (property=Samples sufficiently large)| power analysis performed (property=power analysis performed)| reasons given for samples (property=reasons given for samples)| Ethnicity mentioned (property=Ethnicity mentioned)| Possibility of attention effects (property=Possibility of attention effects)| Possibility of placebo effects (property=Possibility of placebo effects)| Other reasons (property=Other reasons)| Testing for normal distribution (property=Testing for normal distribution)| Correct application of statistical (property=Correct application of statistical)| Correction for multiple testing (property=Correction for multiple testing)| Measurement of compliance (property=Measurement of compliance)| Blinding reliable (property=Blinding reliable)| Check whether blinding was successful (property=Check whether blinding was successful)| Consistent reporting in numbers (property=Consistent reporting in numbers)| Sufficient washout period (property=Sufficient washout period)| Tested for carry-over (property=Tested for carry-over)| Were sequence effects tested (property=Were sequence effects tested)| Comprehensive and coherent reporting (property=Comprehensive and coherent reporting)| Were side effects systematically recorded (property=Were side effects systematically recorded)| Effect sizes reported (property=Effect sizes reported)| Side effects taken into account in the interpretation of the results (property=Side effects taken into account in the interpretation of the results)| mono- or multicentric (property=mono- or multicentric)| Ethics / CoI / Funding (property=Ethics / CoI / Funding)}}
</noinclude><includeonly>{| class="wikitable" style="width:75%;"
</noinclude><includeonly>
==Sample==
{| class="wikitable" style="width:100%;"
|-
|-
! width=33% style="text-align:left;" | Samples sufficiently large
! width=70% style="text-align:left;" | Power analysis performed
| [[Samples sufficiently large::{{{Samples sufficiently large|}}}]]
| style="text-align:left;" | [[power analysis performed::{{{power analysis performed|}}}]]
|-
|-
! style="text-align:left;" | Power analysis performed
! style="text-align:left; text-indent:3em;" | - Sample size corresponds to power analysis
| [[power analysis performed::{{{power analysis performed|}}}]]
| style="text-align:left;" | [[Sample size corresponds to power analysis::{{{Sample size corresponds to power analysis|}}}]]
|-
|-
! style="text-align:left;" | Reasons given for samples being too small according to power analysis  
! style="text-align:left; text-indent:3em;" | - Reasons for insufficient sample size based on power analysis  
| style="white-space: pre-wrap;" | [[reasons given for samples being too small according to power analysis::{{{reasons given for samples being too small according to power analysis|}}}]]
| style="text-align:left;" | [[Reasons given for samples being too small according to power analysis::{{{Reasons given for samples being too small according to power analysis|}}}]]
|-
! style="text-align:left;" | If no power analysis performed: at least moderate sample size (n >= 30 per arm)
| style="text-align:left;" | [[Samples sufficiently large::{{{Samples sufficiently large|}}}]]
|-
|-
! style="text-align:left;" | Ethnicity mentioned  
! style="text-align:left;" | Ethnicity mentioned  
| [[Ethnicity mentioned::{{{Ethnicity mentioned|}}}]]
| style="text-align:left;" | [[Ethnicity mentioned::{{{Ethnicity mentioned|}}}]]
|}
|}
==Are there other explanations for an effect besides the investigated intervention?==
==Alternative Explanation==
{| class="wikitable" style="width:75%;"
{| class="wikitable" style="width:100%;"
|-
! width=30% style="text-align:left;" | Other explanations for an effect besides the investigated intervention
| style="text-align:left;" | [[Other explanations for an effect besides the investigated intervention::{{{Other explanations for an effect besides the investigated intervention|}}}]]
|-
|-
! width=33% style="text-align:left;" | Possibility of attention effects  
! style="text-align:left; text-indent:3em;" | - Possibility of attention effects  
| [[Possibility of attention effects::{{{Possibility of attention effects|}}}]]
| [[Possibility of attention effects::{{{Possibility of attention effects|}}}]]
|-
|-
! style="text-align:left;" | Possibility of placebo effects  
! style="text-align:left; text-indent:3em;" | - Possibility of placebo effects  
| [[Possibility of placebo effects::{{{Possibility of placebo effects|}}}]]
| [[Possibility of placebo effects::{{{Possibility of placebo effects|}}}]]
|-
|-
! style="text-align:left;" | Other reasons  
! style="text-align:left; text-indent:3em;" | - Other reasons  
| style="white-space: pre-wrap;" | [[Other reasons::{{{Other reasons|}}}]]
| [[Other reasons::{{{Other reasons|}}}]]
|}
|}
==Statistics==
==Statistics==
{| class="wikitable" style="width:75%;"
{| class="wikitable" style="width:100%;"
|-
! width=33% style="text-align:left;" | Testing for normal distribution
| [[Testing for normal distribution::{{{Testing for normal distribution|}}}]]
|-
|-
! style="text-align:left;" | Correct application of statistical tests  
! width=70% style="text-align:left;" | Correct use of parametric and non-parametric tests {{#info: Testing for normal distribution only necessary if parametric tests are used, NI: use of parametric tests without report of normal distribution testing| note}}
| [[Correct application of statistical tests::{{{Correct application of statistical tests|}}}]]
| style="text-align:left;" | [[Correct use of parametric and non-parametric tests::{{{Correct use of parametric and non-parametric tests|}}}]]
|-
|-
! style="text-align:left;" | Correction for multiple testing  
! style="text-align:left;" | Correction for multiple testing  
| [[Correction for multiple testing::{{{Correction for multiple testing|}}}]]
| style="text-align:left;" | [[Correction for multiple testing::{{{Correction for multiple testing|}}}]]
|-
|-
! style="text-align:left;" | Measurement of compliance  
! style="text-align:left;" | Measurement of compliance  
| [[Measurement of compliance::{{{Measurement of compliance|}}}]]
| style="text-align:left;" | [[Measurement of compliance::{{{Measurement of compliance|}}}]]
|-
|-
! style="text-align:left;" | Blinding reliable
! style="text-align:left;" | Consistent reporting in numbers (figures, flowchart, abstract, results)
| [[Blinding reliable::{{{Blinding reliable|}}}]]
| style="text-align:left;" | [[Consistent reporting in numbers::{{{Consistent reporting in numbers|}}}]]
|-
|-
! style="text-align:left;" | Check whether blinding was successful
! style="text-align:left;" | Comprehensive and coherent reporting
| [[Check whether blinding was successful::{{{Check whether blinding was successful|}}}]]
| style="text-align:left;" | [[Comprehensive and coherent reporting::{{{Comprehensive and coherent reporting|}}}]]
|-
|-
! style="text-align:left;" | Consistent reporting in numbers
! style="text-align:left;" | Cross-over
| [[Consistent reporting in numbers::{{{Consistent reporting in numbers|}}}]]
| style="text-align:left;" | [[Cross-over::{{{Cross-over|}}}]]
|-
|-
! style="text-align:left;" | Sufficient washout period  
! style="text-align:left; text-indent:3em;" | - Sufficient washout period  
| [[sufficient washout period::{{{sufficient washout period|}}}]]
| style="text-align:left;" | [[sufficient washout period::{{{sufficient washout period|}}}]]
|-
|-
! style="text-align:left;" | Tested for carry-over effects
! style="text-align:left; text-indent:3em;" | - Tested for carry-over effects  
| [[Tested for carry-over effects::{{{Tested for carry-over effects|}}}]]
| style="text-align:left;" | [[Tested for carry-over effects::{{{Tested for carry-over effects|}}}]]
|-
! style="text-align:left;" | Were sequence effects tested
| [[Were sequence effects tested::{{{Were sequence effects tested|}}}]]
|-
! style="text-align:left;" | Comprehensive and coherent reporting
| [[Comprehensive and coherent reporting::{{{Comprehensive and coherent reporting|}}}]]
|-
|-
! style="text-align:left;" | Were side effects systematically recorded
! style="text-align:left; text-indent:3em;" | - Tested for sequence effects
| [[Were side effects systematically recorded::{{{Were side effects systematically recorded|}}}]]
| style="text-align:left;" | [[Were sequence effects tested::{{{Were sequence effects tested|}}}]]
|}
|}
==Interpretation of results==
==Interpretation of results==
{| class="wikitable" style="width:75%;"
{| class="wikitable" style="width:100%;"
|-
|-
! width=33% style="text-align:left;" | Effect sizes reported  
! width=70% style="text-align:left;" | Effect sizes reported (clinical vs. statistical significance)
| [[Effect sizes reported::{{{Effect sizes reported|}}}]]
| style="text-align:left;" | [[Effect sizes reported::{{{Effect sizes reported|}}}]]
|-
|-
! style="text-align:left;" | Side effects taken into account in the interpretation of the results
! style="text-align:left;" | Side effects systematically recorded
| [[Side effects taken into account in the interpretation of the results::{{{Side effects taken into account in the interpretation of the results|}}}]]
| style="text-align:left;" | [[Were side effects systematically recorded::{{{Were side effects systematically recorded|}}}]]
|-
|-
! style="text-align:left;" | Mono- or multicentric
! style="text-align:left;" | Side effects considered in result interpretation
| [[mono- or multicentric::{{{mono- or multicentric|}}}]]
| style="text-align:left;" | [[Side effects taken into account in the interpretation of the results::{{{Side effects taken into account in the interpretation of the results|}}}]]
|-
|-
! style="text-align:left;" | Ethics / CoI / Funding
! style="text-align:left;" | Ethics votum
| style="white-space: pre-wrap;" | [[Ethics / CoI / Funding::{{{Ethics / CoI / Funding|}}}]]
| style="text-align:left;" | [[Ethics / CoI / Funding::{{{Ethics / CoI / Funding|}}}]]
|}
|}
</includeonly>
</includeonly>

Latest revision as of 12:09, 6 November 2024

This is the "Further points for assessing the study" template.

It should be called in the following format:

{{Further points for assessing the study
|Samples sufficiently large=
|power analysis performed=
|reasons given for samples=
|Ethnicity mentioned=
|Possibility of attention effects=
|Possibility of placebo effects=
|Other reasons=
|Testing for normal distribution=
|Correct application of statistical=
|Correction for multiple testing=
|Measurement of compliance=
|Blinding reliable=
|Check whether blinding was successful=
|Consistent reporting in numbers=
|Sufficient washout period=
|Tested for carry-over=
|Were sequence effects tested=
|Comprehensive and coherent reporting=
|Were side effects systematically recorded=
|Effect sizes reported=
|Side effects taken into account in the interpretation of the results=
|mono- or multicentric=
|Ethics / CoI / Funding=
}}

Edit the page to see the template text.

Retrieved from "https://camih.med.uni-jena.de/camih/index.php?title=Template:Further_points_for_assessing_the_study&oldid=6377"